These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 521464)

  • 1. An abnormality of cell behaviour in human dystrophic muscle cultures: a time-lapse study.
    Yasin R; Van Beers G; Riddle PN; Brown D; Widdowson G; Thompson EJ
    J Cell Sci; 1979 Aug; 38():201-10. PubMed ID: 521464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired muscle differentiation in explant cultures of Duchenne muscular dystrophy.
    Jasmin G; Tautu C; Vanasse M; Brochu P; Simoneau R
    Lab Invest; 1984 Feb; 50(2):197-207. PubMed ID: 6694359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible manifestation of the dystrophic X chromosome in muscle cultures from carriers of Duchenne muscular dystrophy.
    Thompson EJ; Yasin R; Lake BD; Cavanagh NP
    Exp Neurol; 1983 Mar; 79(3):720-8. PubMed ID: 6825761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between the growth pattern of cell cultures from normal and Duchenne dystrophy muscle.
    Delaporte C; Dehaupas M; Fardeau M
    J Neurol Sci; 1984 May; 64(2):149-60. PubMed ID: 6747662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic analysis and muscle differentiation in a girl with severe muscular dystrophy.
    Meola G; Scarpini E; Velicogna M; Scarlato G; Larizza L; Conti AF
    J Neurol; 1986 Jun; 233(3):168-70. PubMed ID: 3723154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential glucocorticoid effects on the fusion of Duchenne/Becker and control muscle cultures: pharmacologic detection of accelerated aging in dystrophic muscle.
    Hardiman O; Brown RH; Beggs AH; Specht L; Sklar RM
    Neurology; 1992 May; 42(5):1085-91. PubMed ID: 1579232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of skin fibroblast aggregation in Duchenne muscular dystrophy.
    Jones GE; Witkowski JA
    J Cell Sci; 1981 Apr; 48():291-300. PubMed ID: 7276091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis of collagen III, IV, laminin and fibronectin in Duchenne muscular dystrophy biopsies and cell cultures.
    Rampoldi E; Meola G; Conti AM; Velicogna M; Larizza L
    Eur J Cell Biol; 1986 Oct; 42(1):27-34. PubMed ID: 3539608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of normal and genetically dystrophic mouse muscle in tissue culture. I. Prefusion and fusion activities of muscle cells: phase contrast and time lapse study.
    Powell JA
    Exp Cell Res; 1973 Aug; 80(2):251-64. PubMed ID: 4583191
    [No Abstract]   [Full Text] [Related]  

  • 10. Freeze-fracture electronmicroscopic analysis of plasma membranes of cultured muscle cells in Duchenne dystrophy.
    Osame M; Engel AG; Rebouche CJ; Scott RE
    Neurology; 1981 Aug; 31(8):972-9. PubMed ID: 7196524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotation-mediated aggregation of skin fibroblasts in Duchenne muscular dystrophy. Effects of monensin.
    Witkowski JA; Statham HE; Dubowitz V
    J Neurol Sci; 1983; 61(3):425-33. PubMed ID: 6655491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased creatine kinase activity in cultured Duchenne dystrophic muscle cells.
    Iannaccone ST; Nagy B; Samaha FJ
    J Child Neurol; 1987 Jan; 2(1):17-21. PubMed ID: 3624824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased acetylcholine sensitivity in Duchenne muscular dystrophy myotubes.
    Meola G; Mancinelli E; Geremia L; Scarlato G
    Ital J Neurol Sci; 1991 Apr; 12(2):181-5. PubMed ID: 2071364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New approaches to the study of human dystrophic muscle cells in culture.
    Yasin R; Walsh FS; Landon DN; Thompson EJ
    J Neurol Sci; 1983 Mar; 58(3):315-34. PubMed ID: 6341512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased ouabain sensitivity of cultured human fibroblasts from muscular dystrophy.
    Ledbetter ML
    Am J Physiol; 1984 Nov; 247(5 Pt 1):C415-23. PubMed ID: 6093571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle lipids in Duchenne muscular dystrophy.
    Pearce PH; Johnsen RD; Wysocki SJ; Kakulas BA
    Aust J Exp Biol Med Sci; 1981 Feb; 59(1):77-90. PubMed ID: 7236123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein metabolism in Duchenne muscular dystrophy, monoclonal and mixed skeletal muscle cultures.
    Corbett AJ
    Clin Exp Neurol; 1987; 24():214-9. PubMed ID: 3268348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in surface morphology and basal lamina of cultured muscle cells from Duchenne muscular dystrophy patients.
    Delaporte C; Dautreaux B; Rouche A; Fardeau M
    J Neurol Sci; 1990 Jan; 95(1):77-88. PubMed ID: 2338566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine receptors in cultured human muscle cells.
    Franklin GI; Yasin R; Hughes BP; Thompson EJ
    J Neurol Sci; 1980 Sep; 47(3):317-27. PubMed ID: 7420110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid therapy is associated with decreased numbers of dendritic cells and fibroblasts, and increased numbers of satellite cells, in the dystrophic skeletal muscle.
    Hussein MR; Abu-Dief EE; Kamel NF; Mostafa MG
    J Clin Pathol; 2010 Sep; 63(9):805-13. PubMed ID: 20819882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.